“Abemaciclib in Real Clinical Practice of Adjuvant Therapy of HR+ HER2- High-Risk Breast Cancer: Experience of Centers in Moscow”. 2025. Voprosy Onkologii 71 (3): OF-2319. https://doi.org/10.37469/0507-3758-2025-71-3-OF-2319.